Kinga Krzysztoforska

Dr. Kinga Krzysztoforska

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2017 in Nutritional Neuroscience
Verified
Journal Article
Closed access
KKKinga Krzysztoforska
Kinga Krzysztoforska
DMDagmara Mirowska-Guzel
Dagmara Mirowska-Guzel
EWEwa Widy-Tyszkiewicz
Ewa Widy-Tyszkiewicz
Protocatechuic acid has very promising properties potentially useful in the inhibition of neurodegenerative diseases progression. It is the main metabolite of the complex polyphenolic compounds and is believed to be responsible for beneficial effects associated with consumption of the food products rich in polyphenols. Protocatechuic acid is present in the circulation significantly longer and at higher concentrations than parent compounds and easily crosses the blood brain barrier. The aim of the following paper is to provide an extensive and actual report on protocatechuic acid and its pharmacological potential in prevention and/or treatment of neurodegenerative diseases in humans based on existing data from both in vitro and in vivo studies. Experimental studies strongly support the role of protocatechuic acid in the prevention of neurodegenerative processes, including Alzheimer’s and Parkinson’s diseases, due to its favorable influence on processes underlying cognitive and behavioral impairment, namely accumulation of the β-amyloid plaques in brain tissues, hyperphosphorylation of tau protein in neurons, excessive formation of reactive oxygen species and neuroinflammation. There is a growing evidence that protocatechuic acid may become in the future efficacious and safe substance that protects against neurodegenerative disorders.

1 August 2019 in Behavioural Brain Research
Verified
Journal Article
Closed access
KKKinga Krzysztoforska
Kinga Krzysztoforska
APAgnieszka Piechal
Agnieszka Piechal
KBKamilla Blecharz-Klin
Kamilla Blecharz-Klin
JPJustyna Pyrzanowska
Justyna Pyrzanowska
IJIlona Joniec-Maciejak
Ilona Joniec-Maciejak
EWEwa Widy-Tyszkiewicz
Ewa Widy-Tyszkiewicz

21 December 2020 in Nutritional Neuroscience
Verified
Journal Article
Closed access
KKKinga Krzysztoforska
Kinga Krzysztoforska
APAgnieszka Piechal
Agnieszka Piechal
KBKamilla Blecharz-Klin
Kamilla Blecharz-Klin
JPJustyna Pyrzanowska
Justyna Pyrzanowska
IJIlona Joniec-Maciejak
Ilona Joniec-Maciejak
EWEwa Widy-Tyszkiewicz
Ewa Widy-Tyszkiewicz
: This study aimed to investigate the influence of protocatechuic acid (PCA) on learning, memory, and central nervous system (CNS) neuromodulators in healthy rats, to analyse whether the procogniti...

26 January 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
KKKinga Krzysztoforska
Kinga Krzysztoforska
APAgnieszka Piechal
Agnieszka Piechal
EMEwa Machaj
Ewa Machaj
KBKamilla Blecharz-Klin
Kamilla Blecharz-Klin
JPJustyna Pyrzanowska
Justyna Pyrzanowska
EWEwa Widy-Tyszkiewicz
Ewa Widy-Tyszkiewicz
The purpose of this research was to investigate the effects of protocatechuic acid (PCA) at doses of 50 and 100 mg/kg on the development of unfavourable changes in cognitive processes in a pyrithiamine-induced thiamine deficiency (PTD) model of the Wernicke–Korsakoff syndrome (WKS) in rats. The effects of PCA were assessed at the behavioural and biochemical levels. Behavioural analysis was conducted using the Foot Fault test (FF), Bar test, Open Field test, Novel Object Recognition test (NOR), Hole–Board test and Morris Water Maze test (MWM). Biochemical analysis consisting of determination of concentration and turnover of neurotransmitters in selected structures of the rat CNS was carried out using high-performance liquid chromatography. PTD caused catalepsy (Bar test) and significantly impaired motor functions, leading to increased ladder crossing time and multiplied errors due to foot misplacement (FF). Rats with experimentally induced WKS showed impaired consolidation and recall of spatial reference memory in the MWM test, while episodic memory related to object recognition in the NOR was unimpaired. Compared to the control group, rats with WKS showed reduced serotonin levels in the prefrontal cortex and changes in dopamine and/or norepinephrine metabolites in the prefrontal cortex, medulla oblongata and spinal cord. PTD was also found to affect alanine, serine, glutamate, and threonine levels in certain areas of the rat brain. PCA alleviated PTD-induced cataleptic symptoms in rats, also improving their performance in the Foot Fault test. In the MWM, PCA at 50 and 100 mg/kg b.w. improved memory consolidation and the ability to retrieve acquired information in rats, thereby preventing unfavourable changes caused by PTD. PCA at both tested doses was also shown to have a beneficial effect on normalising PTD-disrupted alanine and glutamate concentrations in the medulla oblongata. These findings demonstrate that certain cognitive deficits in spatial memory and abnormalities in neurotransmitter levels persist in rats that have experienced an acute episode of PTD, despite restoration of thiamine supply and long-term recovery. PCA supplementation largely had a preventive effect on the development of these deficits, to some extent also normalising neurotransmitter concentrations in the brain.

16 September 2021 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
PDF file
APAgnieszka Piechal
Agnieszka Piechal
KBKamilla Blecharz-Klin
Kamilla Blecharz-Klin
IJIlona Joniec-Maciejak
Ilona Joniec-Maciejak
JPJustyna Pyrzanowska
Justyna Pyrzanowska
KKKinga Krzysztoforska
Kinga Krzysztoforska
EWEwa Widy-Tyszkiewicz
Ewa Widy-Tyszkiewicz
Introduction: Dihydroergotamine (DHE) is a derivative of an ergot alkaloid used as an antimigraine medication. Nowadays, ergot alkaloids may still endanger the safety of humans and animals as food or medicine pollutants, but the outcomes of long-term DHE administration on the behaviour and...